유럽 연합 -
에스토니아어 -
EMA (European Medicines Agency)
tezspire
astrazeneca ab - tezepelumab - astma - ravimid hingamisteede obstruktiivsete haiguste, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
에스토니아 -
에스토니아어 -
Ravimiamet
spirix tablett
orifarm healthcare a/s - spironolaktoon - tablett - 100mg 20tk
에스토니아 -
에스토니아어 -
Ravimiamet
spirix tablett
orifarm healthcare a/s - spironolaktoon - tablett - 25mg 20tk; 25mg 100tk; 25mg 60tk
에스토니아 -
에스토니아어 -
Ravimiamet
spirix tablett
orifarm healthcare a/s - spironolaktoon - tablett - 50mg 20tk
에스토니아 -
에스토니아어 -
Ravimiamet
aspirin i.v 500 mg süste-/infusioonilahuse pulber ja lahusti
bayer ag - atsetüülsalitsüülhape - süste-/infusioonilahuse pulber ja lahusti - 500mg 5tk
에스토니아 -
에스토니아어 -
Ravimiamet
aspirin-c kihisev tablett
bayer uab - atsetüülsalitsüülhape+askorbiinhape - kihisev tablett - 400mg+240mg 10tk
에스토니아 -
에스토니아어 -
Ravimiamet
aspirin tablett
bayer uab - atsetüülsalitsüülhape - tablett - 500mg 20tk; 500mg 100tk; 500mg 50tk